The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

The blockbuster weight loss drug Wegovy has a new rival. Today, the US Food and Drug Administration approved a new drug for weight management called Zepbound, made by American pharmaceutical company Eli Lilly.

The weekly injectable drug is meant for adults who are overweight or obese and have at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol. The active ingredient in Zepbound, tirzepatide, is already approved under the brand name Mounjaro to help improve blood sugar in adults with type 2 diabetes and is widely prescribed off-label for weight loss.

Zepbound and Mounjaro are similar to the better-known Wegovy and Ozempic, which are both

→ Continue reading at Wired - Science

More from author

Related posts

Advertisment

Latest posts

Janet Yellen to host China’s top economic official ahead of expected Biden-Xi talks in San Francisco | CNN Business

Editor’s Note: Sign up for CNN’s Meanwhile in China newsletter which explores what you need to know about the country’s rise and how...

Actors union reaches tentative deal with Hollywood and TV studios | CNN Business

New York CNN  —  Hollywood actors have reached a tentative agreement with the major film and television studios to...

4 Entrepreneurial Lessons We Learned from Oakley Sunglasses Founder

Opinions expressed by Entrepreneur contributors are their own. This story originally appeared on Under30CEO.comSome entrepreneurs do not take a traditional path to...